
Benzinga Pro data, DermTech (NASDAQ:DMTK) reported Q1 sales of $3.72 million. Earnings fell to a loss of $30.11 million, resulting in a 15.56% decrease from last quarter. In Q4, DermTech brought in $3.17 million in sales but lost $26.05 million in earnings.